[HTML][HTML] Heparin versus bivalirudin in acute myocardial infarction: Unfractionated heparin monotherapy elevated to primary treatment in contemporary percutaneous …
OA Centurión - The Open Cardiovascular Medicine Journal, 2016 - ncbi.nlm.nih.gov
Bivalirudin, a direct thrombin inhibitor, was developed as an antithrombin agent for patients
undergoing percutaneous coronary interventions (PCI) with the hypothesis that it would …
undergoing percutaneous coronary interventions (PCI) with the hypothesis that it would …
Heparin Versus Bivalirudin in Acute Myocardial Infarction: Unfractionated Heparin Monotherapy Elevated to Primary Treatment in Contemporary Percutaneous …
OA Centurión - The Open Cardiovascular Medicine Journal, 2016 - europepmc.org
Bivalirudin, a direct thrombin inhibitor, was developed as an antithrombin agent for patients
undergoing percutaneous coronary interventions (PCI) with the hypothesis that it would …
undergoing percutaneous coronary interventions (PCI) with the hypothesis that it would …
[PDF][PDF] The Open Cardiovascular Medicine
Open Cardiovascular Medicine Journal, 2016 - scienceopen.com
Bivalirudin, a direct thrombin inhibitor, was developed as an antithrombin agent for patients
undergoing percutaneous coronary interventions (PCI) with the hypothesis that it would …
undergoing percutaneous coronary interventions (PCI) with the hypothesis that it would …
[HTML][HTML] Heparin Versus Bivalirudin in Acute Myocardial Infarction: Unfractionated Heparin Monotherapy Elevated to Primary Treatment in Contemporary …
OA Centurión - The Open Cardiovascular …, 2016 - opencardiovascularmedicinejournal …
Bivalirudin, a direct thrombin inhibitor, was developed as an antithrombin agent for patients
undergoing percutaneous coronary interventions (PCI) with the hypothesis that it would …
undergoing percutaneous coronary interventions (PCI) with the hypothesis that it would …
[PDF][PDF] The Open Cardiovascular Medicine
Open Cardiovascular Medicine Journal, 2016 - pdfs.semanticscholar.org
Bivalirudin, a direct thrombin inhibitor, was developed as an antithrombin agent for patients
undergoing percutaneous coronary interventions (PCI) with the hypothesis that it would …
undergoing percutaneous coronary interventions (PCI) with the hypothesis that it would …
Heparin Versus Bivalirudin in Acute Myocardial Infarction: Unfractionated Heparin Monotherapy Elevated to Primary Treatment in Contemporary Percutaneous …
OA Centurión - The Open Cardiovascular Medicine Journal, 2016 - benthamopen.com
Bivalirudin, a direct thrombin inhibitor, was developed as an antithrombin agent for patients
undergoing percutaneous coronary interventions (PCI) with the hypothesis that it would …
undergoing percutaneous coronary interventions (PCI) with the hypothesis that it would …
[PDF][PDF] The Open Cardiovascular Medicine
Open Cardiovascular Medicine Journal, 2016 - researchgate.net
Bivalirudin, a direct thrombin inhibitor, was developed as an antithrombin agent for patients
undergoing percutaneous coronary interventions (PCI) with the hypothesis that it would …
undergoing percutaneous coronary interventions (PCI) with the hypothesis that it would …
Heparin Versus Bivalirudin in Acute Myocardial Infarction: Unfractionated Heparin Monotherapy Elevated to Primary Treatment in Contemporary Percutaneous …
OA Centurión - The open cardiovascular medicine journal, 2016 - pubmed.ncbi.nlm.nih.gov
Bivalirudin, a direct thrombin inhibitor, was developed as an antithrombin agent for patients
undergoing percutaneous coronary interventions (PCI) with the hypothesis that it would …
undergoing percutaneous coronary interventions (PCI) with the hypothesis that it would …
[PDF][PDF] The Open Cardiovascular Medicine
Open Cardiovascular Medicine Journal, 2016 - researchgate.net
Bivalirudin, a direct thrombin inhibitor, was developed as an antithrombin agent for patients
undergoing percutaneous coronary interventions (PCI) with the hypothesis that it would …
undergoing percutaneous coronary interventions (PCI) with the hypothesis that it would …
[HTML][HTML] Heparin Versus Bivalirudin in Acute Myocardial Infarction: Unfractionated Heparin Monotherapy Elevated to Primary Treatment in Contemporary …
OA Centurión - The Open Cardiovascular …, 2016 - opencardiovascularmedicinejournal …
Bivalirudin, a direct thrombin inhibitor, was developed as an antithrombin agent for patients
undergoing percutaneous coronary interventions (PCI) with the hypothesis that it would …
undergoing percutaneous coronary interventions (PCI) with the hypothesis that it would …